Immunoassay Market

Industry Overview

In scientific research, immunoassay is frequently used to track various proteins, hormones, and antibodies in order to analyze biological systems. In the workplace, they are used to monitor particular molecules utilized in the production of products as well as to detect toxins in food and water.

The size of the Global Immunoassay Market, which was estimated at USD 28.1 billion in 2023, has been expanded and is anticipated to rise at a CAGR of 6.7% from 2025 to 2030. Growth will also be aided by the increase in the elderly population, who are more susceptible to infections and chronic diseases. The widespread use of immunoassay techniques in illness diagnostics is a result of a rise in the incidence of chronic ailments such cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases. Due to the rising use of immunoassay tests and the prevalence of chronic and infectious diseases, the market has seen a high demand for kits and reagents in recent years.

Market Segmentation

Insight by the Product and Services

The Immunoassay market is split into analyzers, reagents & kits, and software & services based on products and services. With a revenue share of over 60.0% in 2022, the reagents and kits segment dominated the immunoassay market. Over the forecast period, the segment is anticipated to keep up its lead. Due to the rising incidence of viral and autoimmune disorders, there is a significant demand for immunoassay reagents and kits for diagnostic purposes. Additionally, it is anticipated that the approval and introduction of innovative immunoassay kits will help the segment's expansion. Due to the need for repeat purchases of kits and reagents, the increasing number of immunoassay tests, and the rising incidence of chronic and infectious diseases, the reagents and kits category had the biggest market share of all the products and services.

Insight by Platform

Key Platforms

Radioimmunoassays (RIAs), Colorimetric immunoassays (CIs),Chemiluminescence immunoassays (CLIAs),Fluorescence immunoassays (FIAs) and Others

Market Player Platform - Chemiluminescence immunoassays (CLIAs)

The CLIAs have the largest market share across all platforms in the immunoassay industry which was valued at USD 7.34 billion in 2020 has the expected CAGR 6.3% for the period of 2025 to 2030. CLIA widely used in the detection of chronic diseases such cancer, diabetes, autoimmune disease, cardiovascular disease, and infectious and autoimmune disorders.

Insight by Technology

Key immunoassay market technologies

Enzyme-Linked Immunosorbent Assays (ELISA), Enzyme-linked immunospot,Immuno-PCR, fast testing, Western blotting, and other technologies.

Market player technology- Enzyme-Linked Immunosorbent Assays(ELISA),

The Enzyme-Linked Immunosorbent Assays held the biggest market share because of frequent test of wide range of infectious and chronic illnesses such as HIV and AIDS. The immunoassays across all technologies has anticipated to reach US$ 2,016.1 million in value in 2023 and its expected CAGR for next five year (2025-2030) is of 6.4% to reach the value of US$ 4.02 billion.

Insight by Specimen Type

The market is segmented into blood, urine, saliva, and other specimen types. Due to the rising incidence of infectious and chronic diseases and number of blood donors, the blood specimen had the biggest proportion of all specimen types. It is predicted to increase at the fastest rate in the immunoassay market. The market size of blood specimen was valued at USD 82.5 billion and is expected to grow with the CAGR of 8.3% till in 2028.

Insight by Application

Market Segments

Infectious illnesses, oncology, cardiology, autoimmune disorders, neonatal screening, endocrinology, bone & mineral disorders, hematology & blood screening, toxicology, and others

Market Player - Infectious Disease treatment

Expected CAGR (2025-2030) - 8.0% to reach the value of US$ 106.3

Factors affecting the growth

Frequent incidence occurrence of infectious diseases and the increasing number of product approvals.

Insight by End User

Market Segments

Hospitals, Blood banks, Clinical Laboratories, pharmaceutical, biotechnology companies, Contract Research Organization (CROs) and research and academic laboratories and others.

Market Players - Hospitals and clinical

Hospitals are the primary end-user in the immunoassay industry. With a projected 81% market share for diagnostic testing at hospitals, hospitals are expected to dominate. The tests at hospitals give the best time and cost savings, and they also have a straightforward method. It is projected that the widespread use of ELISA in blood banks to treat infectious diseases would lead to an increase in immunoassay testing in hospitals. The blood bank sector will benefit from the increase in blood transfusions.

Global Immunoassay Market Report Coverage

Industry Dynamics

The outbreak of Covid-19 affected the immunoassay industry. The market vendors' assessments, strategies, technology assessments, product mapping, industry outlook, economic analysis, segmental analysis, immunoassay market sizing, and analysis tables have all been impacted. With exclusive, in-depth market data, Vynz researches the revenue potential of all high-growth technologies, improving the yearly increases in sales. We have been able to locate new revenue prospects in specialized industries with rapid growth thanks to our knowledge. Our ability to use the client in conjunction with a planned strategy to build an ascending business model has been significantly improved by comprehensive data assets and our revenue model. To understand the present and future state of the immunoassay market and how it will affect the company's income, VynZ research offers a thorough analysis of every sector.

Growth Drivers

The main growth factors for the immunoassay market are technological advancements in immunoassay instruments, immunoassays' critical role in drug and alcohol analysis, the increasing acceptance of immunoassay-based point-of-care testing, and rapid testing and development in the biotechnology and biopharmaceutical industries. Additionally, as a consequence of technological breakthroughs, the major market players are consistently working to offer small, dependable, and portable products, which supports market demand.

Challenges

The main obstacles to the expansion of the immunoassay market are the stringent regulatory requirements for the approval of immunoassay instruments and consumables, the use of excise duty on the sale of medical devices in the U.S., the difficulty of conducting diagnostic tests, and the unfavorable compensation environment. According to a projection by the UN Department of Economic and Social Affairs (UNDESA), there will be 1.4 billion individuals in the world who are 60 years of age or older by 2030, up from 901 million in 2015. This is a global increase of 56%. The number of senior citizens worldwide is anticipated to be around 2.1 billion by 2050. In addition, by 2050, there will be over 437 million individuals in China and 324 million in India who are 60 years of age or older. The market for immunoassay equipment will eventually rise as a result of the growing elderly population.

Geographic Overview

The largest market for immunoassays is the North America. The expansion of this immunoassay market is also being driven by the availability of government resources, rising use of immunoassays in clinical diagnostics, improved healthcare infrastructure. Germany contributed to the biggest revenue share of 23.7%, and is anticipated to expand significantly due to the country's supportive healthcare regulations.

Due to its dense population, the Asia-Pacific region is expected to have the market's quickest expansion. Additionally, the region's immunoassay market is growing as a result of rising rates of chronic illnesses and infectious diseases as well as improved healthcare infrastructure.

Competitive Insight

Market participants are bolstering their positions in the immunoassay instruments market by buying up other comparable businesses. Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation are a few of the other major competitors in the market for immunoassay devices. The study evolves the market size information for a number of nations, including the United States, Canada, Germany, the United Kingdom, France, Italy, Spain, China, Japan, India, and Brazil.

The Immunoassay Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product & Services
  • Analyzers
  • Reagents & Kit
  • Software
  • Services
• By Platform 
  • Chemiluminescence
  • Colorimetric
  • Fluorescence
  • Radioimmunoassays
  • Others
• By Technology 
  • Enzyme-Linked Immunosorbent Assays,
  • Enzyme-Linked Immunospot
  • Immuno-PCR
  • Rapid Tests
  • Western Blotting
  • Others
• By Specimen Type
  • Blood
  • Urine
  • Saliva
  • Others
• By Application
  • Infectious Diseases
  • Oncology
  • Cardiology
  • Autoimmune Disorders
  • Neonatal Screening
  • Endocrinology
  • Bone & Mineral Disorders
  • Hematology & Blood Screening
  • Toxicology
  • Others
• By End User 
  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies & CROs
  • Research & Academic Laboratories
  • Others

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

PRIMARY RESEARCH INTERVIEWS - BREAKDOWN

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Product & Services
                1.2.2.    By Platform
                1.2.3.    By Technology
                1.2.4.    By Specimen Type
                1.2.5.    By Application
                1.2.6.    By End User               
                1.2.7.    By Region
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                1.5.1.    Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2.    Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Product & Services
                5.1.1.    Analyzers
                        5.1.1.1. Market Definition
                        5.1.1.2. Market Estimation and Forecast to 2030  
                5.1.2.    Reagents & Kit
                        5.1.2.1. Market Definition
                        5.1.2.2. Market Estimation and Forecast to 2030
                5.1.3.    Software
                        5.1.3.1. Market Definition
                        5.1.3.2. Market Estimation and Forecast to 2030
                5.1.4.    Services
                        5.1.4.1. Market Definition
                        5.1.4.2. Market Estimation and Forecast to 2030        
        5.2.    By Platform
                5.2.1.    Chemiluminescence
                        5.2.1.1. Market Definition
                        5.2.1.2. Market Estimation and Forecast to 2030
                5.2.2.    Colorimetric
                        5.2.2.1. Market Definition
                        5.2.2.2. Market Estimation and Forecast to 2030
                5.2.3.    Fluorescence
                        5.2.3.1. Market Definition
                        5.2.3.2. Market Estimation and Forecast to 2030
                5.2.4.    Radioimmunoassays
                        5.2.4.1. Market Definition
                        5.2.4.2. Market Estimation and Forecast to 2030
                5.2.5.    Others
                        5.2.5.1. Market Definition
                        5.2.5.2. Market Estimation and Forecast to 2030        
        5.3.    By Technology   
                5.3.1.    Enzyme-Linked Immunosorbent Assays,
                        5.3.1.1. Market Definition
                        5.3.1.2. Market Estimation and Forecast to 2030
                5.3.2.    Enzyme-Linked Immunospot
                        5.3.2.1. Market Definition
                        5.3.2.2. Market Estimation and Forecast to 2030
                5.3.3.    Immuno-PCR
                        5.3.3.1. Market Definition
                        5.3.3.2. Market Estimation and Forecast to 2030
                5.3.4.    Rapid Tests
                        5.3.4.1. Market Definition
                        5.3.4.2. Market Estimation and Forecast to 2030
                5.3.5.    Western Blotting
                        5.3.5.1. Market Definition
                        5.3.5.2. Market Estimation and Forecast to 2030
                5.3.6.    Others
                        5.3.6.1. Market Definition
                        5.3.6.2. Market Estimation and Forecast to 2030
               5.4.    By Specimen Type   
                5.4.1.    Blood
                        5.4.1.1. Market Definition
                        5.4.1.2. Market Estimation and Forecast to 2030
                5.4.2.    Urine
                        5.4.2.1. Market Definition
                        5.4.2.2. Market Estimation and Forecast to 2030
                5.4.3.    Saliva
                        5.4.3.1. Market Definition
                        5.4.3.2. Market Estimation and Forecast to 2030
                5.4.4.    Others
                        5.4.4.1. Market Definition
                        5.4.4.2. Market Estimation and Forecast to 2030        
        5.5.    By Application
                5.5.1.    Infectious Diseases
                        5.5.1.1. Market Definition
                        5.5.1.2. Market Estimation and Forecast to 2030
                5.5.2.    Oncology
                        5.5.2.1. Market Definition
                        5.5.2.2. Market Estimation and Forecast to 2030
                5.5.3.    Cardiology
                        5.5.3.1. Market Definition
                        5.5.3.2. Market Estimation and Forecast to 2030
                5.5.4.    Autoimmune Disorders
                        5.5.4.1. Market Definition
                        5.5.4.2. Market Estimation and Forecast to 2030
                5.5.5.    Neonatal Screening
                        5.5.5.1. Market Definition
                        5.5.5.2. Market Estimation and Forecast to 2030
                5.5.6.    Endocrinology
                        5.5.6.1. Market Definition
                        5.5.6.2. Market Estimation and Forecast to 2030
                5.5.7.    Bone & Mineral Disorders
                        5.5.7.1. Market Definition
                        5.5.7.2. Market Estimation and Forecast to 2030
                5.5.8.    Hematology & Blood Screening
                        5.5.8.1. Market Definition
                        5.5.8.2. Market Estimation and Forecast to 2030
                5.5.9.    Toxicology
                        5.5.9.1. Market Definition
                        5.5.9.2. Market Estimation and Forecast to 2030
                5.5.10.   Others
                        5.5.10.1. Market Definition
                        5.5.10.2. Market Estimation and Forecast to 2030
        5.6.    By End User
                5.6.1.    Hospitals
                        5.6.1.1. Market Definition
                        5.6.1.2. Market Estimation and Forecast to 2030
                5.6.2.    Blood Banks
                        5.6.2.1. Market Definition
                        5.6.2.2. Market Estimation and Forecast to 2030
                5.6.3.    Clinical Laboratories
                        5.6.3.1. Market Definition
                        5.6.3.2. Market Estimation and Forecast to 2030
                5.6.4.    Pharmaceutical and Biotechnology Companies & CROs
                        5.6.4.1. Market Definition
                        5.6.4.2. Market Estimation and Forecast to 2030
                5.6.5.    Research & Academic Laboratories
                        5.6.5.1. Market Definition
                        5.6.5.2. Market Estimation and Forecast to 2030
                5.6.6.    Others
                        5.6.6.1. Market Definition
                        5.6.6.2. Market Estimation and Forecast to 2030       
        
6.    North America Market Estimate and Forecast

        6.1.    By Product & Services
        6.2.    By Platform
        6.3.    By Technology
        6.4.    By Specimen Type 
        6.5.    By Application
        6.6.    By End User        
        6.7.    By Country
                6.7.1.    U.S. Market Estimate and Forecast
                6.7.2.    Canada Market Estimate and Forecast
                6.7.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Product & Services
        7.2.    By Platform
        7.3.    By Technology
        7.4.    By Specimen Type 
        7.5.    By Application
        7.6.    By End User        
        7.7.    By Country
                7.7.1.    Germany Market Estimate and Forecast
                7.7.2.    France Market Estimate and Forecast
                7.7.3.    U.K. Market Estimate and Forecast
                7.7.4.    Italy Market Estimate and Forecast
                7.7.5.    Spain Market Estimate and Forecast
                7.7.6.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Product & Services
        8.2.    By Platform
        8.3.    By Technology
        8.4.    By Specimen Type 
        8.5.    By Application
        8.6.    By End User        
        8.7.    By Country
                8.7.1.    China Market Estimate and Forecast
                8.7.2.    Japan Market Estimate and Forecast
                8.7.3.    India Market Estimate and Forecast
                8.7.4.    South Korea Market Estimate and Forecast
                8.7.5.    Singapore Market Estimate and Forecast
                8.7.6.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Product & Services
        9.2.    By Platform
        9.3.    By Technology
        9.4.    By Specimen Type 
        9.5.    By Application
        9.6.    By End User        
        9.7.    By Country
                9.7.1.    Brazil Market Estimate and Forecast
                9.7.2.    Saudi Arabia Market Estimate and Forecast
                9.7.3.    South Africa Market Estimate and Forecast
                9.7.4.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    Thermo Fisher Scientific Inc.
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    Ortho Clinical Diagnostics
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    BioMerieux, Inc.
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Abbott Laboratories
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    Sysmex Corporation
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    DiaSorin S.p.A.
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    Siemens Healthcare
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Merck Millipore Corporation
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1  Sources
Table 2  Study Periods
Table 3  Data Reporting Unit
Table 4  Global Immunoassay Market Size, by Product & Services, 2018–2023 (USD Billion)
Table 5  Global Immunoassay Market Size, by Product & Services, 2025–2030 (USD Billion)
Table 6  Global Immunoassay Market Size, by Platform, 2018–2023 (USD Billion)
Table 7  Global Immunoassay Market Size, by Platform, 2025–2030 (USD Billion)
Table 8  Global Immunoassay Market Size, by Technology, 2018–2023 (USD Billion)
Table 9  Global Immunoassay Market Size, by Technology, 2025–2030 (USD Billion)
Table 10  Global Immunoassay Market Size, by Specimen Type, 2018–2023 (USD Billion)
Table 11  Global Immunoassay Market Size, by Specimen Type, 2025–2030 (USD Billion)
Table 12  Global Immunoassay Market Size, by Application, 2018–2023 (USD Billion)
Table 13  Global Immunoassay Market Size, by Application, 2025–2030 (USD Billion)
Table 14  Global Immunoassay Market Size, by End-User, 2018–2023 (USD Billion)
Table 15  Global Immunoassay Market Size, by End-User, 2025–2030 (USD Billion)
Table 16  Global Immunoassay Market Size, by Region, 2018–2023 (USD Billion)
Table 17  Global Immunoassay Market Size, by Region, 2025–2030 (USD Billion)
Table 18  North America Immunoassay Market Size, by Product & Services, 2018–2023 (USD Billion)
Table 19  North America Immunoassay Market Size, by Product & Services, 2025–2030 (USD Billion)
Table 20  North America Immunoassay Market Size, by Platform, 2018–2023 (USD Billion)
Table 21  North America Immunoassay Market Size, by Platform, 2025–2030 (USD Billion)
Table 22  North America Immunoassay Market Size, by Technology, 2018–2023 (USD Billion)
Table 23  North America Immunoassay Market Size, by Technology, 2025–2030 (USD Billion)
Table 24  North America Immunoassay Market Size, by Specimen Type, 2018–2023 (USD Billion)
Table 25  North America Immunoassay Market Size, by Specimen Type, 2025–2030 (USD Billion)
Table 26  North America Immunoassay Market Size, by Application, 2018–2023 (USD Billion)
Table 27  North America Immunoassay Market Size, by Application, 2025–2030 (USD Billion)
Table 28  North America Immunoassay Market Size, by End-User, 2018–2023 (USD Billion)
Table 29  North America Immunoassay Market Size, by End-User, 2025–2030 (USD Billion)
Table 30  North America Immunoassay Market Size, by Country, 2018–2023 (USD Billion)
Table 31  North America Immunoassay Market Size, by Country, 2025–2030 (USD Billion)
Table 32  Europe Immunoassay Market Size, by Product & Services, 2018–2023 (USD Billion)
Table 33  Europe Immunoassay Market Size, by Product & Services, 2025–2030 (USD Billion)
Table 34  Europe Immunoassay Market Size, by Platform, 2018–2023 (USD Billion)
Table 35  Europe Immunoassay Market Size, by Platform, 2025–2030 (USD Billion)
Table 36  Europe Immunoassay Market Size, by Technology, 2018–2023 (USD Billion)
Table 37  Europe Immunoassay Market Size, by Technology, 2025–2030 (USD Billion)
Table 38  Europe Immunoassay Market Size, by Specimen Type, 2018–2023 (USD Billion)
Table 39  Europe Immunoassay Market Size, by Specimen Type, 2025–2030 (USD Billion)
Table 40  Europe Immunoassay Market Size, by Application, 2018–2023 (USD Billion)
Table 41  Europe Immunoassay Market Size, by Application, 2025–2030 (USD Billion)
Table 42  Europe Immunoassay Market Size, by End-User, 2018–2023 (USD Billion)
Table 43  Europe Immunoassay Market Size, by End-User, 2025–2030 (USD Billion)
Table 44  Europe Immunoassay Market Size, by Country, 2018–2023 (USD Billion)
Table 45  Europe Immunoassay Market Size, by Country, 2025–2030 (USD Billion)
Table 46  Asia-Pacific Immunoassay Market Size, by Product & Services, 2018–2023 (USD Billion)
Table 47  Asia-Pacific Immunoassay Market Size, by Product & Services, 2025–2030 (USD Billion)
Table 48  Asia-Pacific Immunoassay Market Size, by Platform, 2018–2023 (USD Billion)
Table 49  Asia-Pacific Immunoassay Market Size, by Platform, 2025–2030 (USD Billion)
Table 50  Asia-Pacific Immunoassay Market Size, by Technology, 2018–2023 (USD Billion)
Table 51  Asia-Pacific Immunoassay Market Size, by Technology, 2025–2030 (USD Billion)
Table 52  Asia-Pacific Immunoassay Market Size, by Specimen Type, 2018–2023 (USD Billion)
Table 53  Asia-Pacific Immunoassay Market Size, by Specimen Type, 2025–2030 (USD Billion)
Table 54  Asia-Pacific Immunoassay Market Size, by Application, 2018–2023 (USD Billion)
Table 55  Asia-Pacific Immunoassay Market Size, by Application, 2025–2030 (USD Billion)
Table 56  Asia-Pacific Immunoassay Market Size, by End-User, 2018–2023 (USD Billion)
Table 57  Asia-Pacific Immunoassay Market Size, by End-User, 2025–2030 (USD Billion)
Table 58  Asia-Pacific Immunoassay Market Size, by Country, 2018–2023 (USD Billion)
Table 59  Asia-Pacific Immunoassay Market Size, by Country, 2025–2030 (USD Billion)
Table 60  RoW Immunoassay Market Size, by Product & Services, 2018–2023 (USD Billion)
Table 61  RoW Immunoassay Market Size, by Product & Services, 2025–2030 (USD Billion)
Table 62  RoW Immunoassay Market Size, by Platform, 2018–2023 (USD Billion)
Table 63  RoW Immunoassay Market Size, by Platform, 2025–2030 (USD Billion)
Table 64  RoW Immunoassay Market Size, by Technology, 2018–2023 (USD Billion)
Table 65  RoW Immunoassay Market Size, by Technology, 2025–2030 (USD Billion)
Table 66  RoW Immunoassay Market Size, by Specimen Type, 2018–2023 (USD Billion)
Table 67  RoW Immunoassay Market Size, by Specimen Type, 2025–2030 (USD Billion)
Table 68  RoW Immunoassay Market Size, by Application, 2018–2023 (USD Billion)
Table 69  RoW Immunoassay Market Size, by Application, 2025–2030 (USD Billion)
Table 70  RoW Immunoassay Market Size, by End-User, 2018–2023 (USD Billion)
Table 71  RoW Immunoassay Market Size, by End-User, 2025–2030 (USD Billion)
Table 72  RoW Immunoassay Market Size, by Country, 2018–2023 (USD Billion)
Table 73  RoW Immunoassay Market Size, by Country, 2025–2030 (USD Billion)
Table 74  Snapshot – F. Hoffmann-La Roche AG
Table 75  Snapshot – Agilent Technologies Inc.
Table 76  Snapshot – Abbott Laboratories Inc.
Table 77  Snapshot – Thermo Fisher Scientific Inc.
Table 78  Snapshot – Siemens AG
Table 79  Snapshot – QIAGEN N.V.
Table 80  Snapshot – Danaher Corporation
Table 81  Snapshot – Ortho Clinical Diagnostics Inc.
Table 82  Snapshot – Sysmex Corporation
Table 83  Snapshot – Bio-Rad Laboratories Inc.
Table 84  Snapshot – BioMérieux SA
Table 85  Snapshot – Becton, Dickinson & Company
Table 86  Snapshot – Mindray

List of Figures

Figure 1  Market Coverage
Figure 2  Research Phases
Figure 3  Secondary Sources for Different Parameters
Figure 4  Methodology
Figure 5  Data Mining & Exploration
Figure 6  Data Triangulation
Figure 7  Assumptions for Market Estimation and Forecast
Figure 8  Executive Summary
Figure 9  Global Immunoassay Market - Growth Drivers and Restraints
Figure 10  Porte’s Five Forces Analysis
Figure 11  Competitive Benchmark
Figure 12  Global Immunoassay Market Highlight
Figure 13  Global Immunoassay Market Size, by Product & Services, 2018 - 2030 (USD Billion)
Figure 14  Global Immunoassay Market Size, by Platform, 2018 - 2030 (USD Billion)
Figure 15  Global Immunoassay Market Size, by Technology, 2018 - 2030 (USD Billion)
Figure 16  Global Immunoassay Market Size, by Specimen, 2018 - 2030 (USD Billion)
Figure 17  Global Immunoassay Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 18  Global Immunoassay Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 19  Global Immunoassay Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 20  North America Immunoassay Market Highlight
Figure 21  North America Immunoassay Market Size, by Product & Services, 2018 - 2030 (USD Billion)
Figure 22  North America Immunoassay Market Size, by Platform, 2018 - 2030 (USD Billion)
Figure 23  North America Immunoassay Market Size, by Technology, 2018 - 2030 (USD Billion)
Figure 24  North America Immunoassay Market Size, by Specimen, 2018 - 2030 (USD Billion)
Figure 25  North America Immunoassay Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 26  North America Immunoassay Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 27  North America Immunoassay Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 28  Europe Immunoassay Market Highlight
Figure 29  Europe Immunoassay Market Size, by Product & Services, 2018 - 2030 (USD Billion)
Figure 30  Europe Immunoassay Market Size, by Platform, 2018 - 2030 (USD Billion)
Figure 31  Europe Immunoassay Market Size, by Technology, 2018 - 2030 (USD Billion)
Figure 32  Europe Immunoassay Market Size, by Specimen, 2018 - 2030 (USD Billion)
Figure 33  Europe Immunoassay Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 34  Europe Immunoassay Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 35  Europe Immunoassay Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 36  Asia-Pacific Immunoassay Market Highlight
Figure 37  Asia-Pacific Immunoassay Market Size, by Product & Services, 2018 - 2030 (USD Billion)
Figure 38  Asia-Pacific Immunoassay Market Size, by Platform, 2018 - 2030 (USD Billion)
Figure 39  Asia-Pacific Immunoassay Market Size, by Technology, 2018 - 2030 (USD Billion)
Figure 40  Asia-Pacific Immunoassay Market Size, by Specimen, 2018 - 2030 (USD Billion)
Figure 41  Asia-Pacific Immunoassay Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 42  Asia-Pacific Immunoassay Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 43  Asia-Pacific Immunoassay Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 44  RoW Immunoassay Market Highlight
Figure 45  RoW Immunoassay Market Size, by Product & Services, 2018 - 2030 (USD Billion)
Figure 46  RoW Immunoassay Market Size, by Platform, 2018 - 2030 (USD Billion)
Figure 47  RoW Immunoassay Market Size, by Technology, 2018 - 2030 (USD Billion)
Figure 48  RoW Immunoassay Market Size, by Specimen, 2018 - 2030 (USD Billion)
Figure 49  RoW Immunoassay Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 50  RoW Immunoassay Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 51  RoW Immunoassay Market Size, by Country, 2018 - 2030 (USD Billion)